1 Min Read
May 16 (Reuters) - Hemispherx Biopharma Inc:
* HEMISPHERX BIOPHARMA REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
* Q1 OPERATING LOSS PER SHARE $0.07 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.